Pantazis P, Han Z, Chatterjee D, Wyche J
Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, R.I., USA.
J Biomed Sci. 1999 Jan;6(1):1-7. doi: 10.1007/BF02256417.
In addition to being causative agents of infectious diseases in animals and humans, DNA viruses have served as models for the study of eukaryotic molecular mechanisms including replication and transcription. Studies of DNA virus functions utilizing cell-free systems and virus-infected cells in culture, in the presence of the anticancer drug camptothecin (CPT), have demonstrated that CPT is a potent inhibitor of replication, transcription and packaging of double-stranded DNA-containing adenoviruses, papovaviruses and herpesviruses, and the single- stranded DNA-containing autonomous parvoviruses. CPT inhibits viral functions by inhibiting topoisomer- ase I, a host cell enzyme required for initiation and completion of the viral functions. These findings indicate that CPT analogues could be developed for use as potent drugs against DNA viruses.
除了作为动物和人类传染病的病原体外,DNA病毒还作为研究包括复制和转录在内的真核分子机制的模型。利用无细胞系统和培养中的病毒感染细胞,在抗癌药物喜树碱(CPT)存在的情况下对DNA病毒功能进行的研究表明,CPT是双链含DNA腺病毒、乳头多瘤空泡病毒和疱疹病毒以及单链含DNA自主细小病毒复制、转录和包装的有效抑制剂。CPT通过抑制拓扑异构酶I来抑制病毒功能,拓扑异构酶I是病毒功能起始和完成所需的宿主细胞酶。这些发现表明,可以开发CPT类似物用作抗DNA病毒的有效药物。